MEMBER ALERT: Updated CDC Guidance for COVID-19 Infection Prevention and Control for HCP


Today, CDC posted updated healthcare personnel infection prevention and control (IP/C) guidance that is captured in three main documents:


Interim Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic


Interim Infection Prevention and Control Recommendations to Prevent SARS-CoV-2 Spread in Nursing Homes


Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2


In an effort to streamline its clinical guidance for healthcare IP/C of COVID-19, CDC is archiving most of the setting-specific guidance and consolidating all healthcare IP/C guidance into the above-listed documents. The new guidance now incorporates considerations for:

  • current local community transmission rates
  • recommendations for immunocompromised people

In addition to the above critical updates, CDC published a number of other updates summarized in a memo posted in our MySHEA document library including:

  • CDC COVID-19 Vaccination Program Provider Agreements
  • Interchangeability of FDA authorized and FDA approved COVID-19 Products
  • Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion
  • Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy
  • Morbidity and Mortality Weekly Report (MMWR) — Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status — 13 U.S. Jurisdictions, April 4–July 17, 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
  • Morbidity and Mortality Weekly Report (MMWR) — Long-Term Symptoms Among Adults Tested for SARS-CoV-2 — United States, January 2020–April 2021
  • ICYMI: September 9 COCA Call: 2021-2022 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines

We hope you find this information helpful.

facebook-2.png twitterlogowhite.png